Factors associated with cerebral white matter hyperintensities in haemodialysis patients

Nephrology

Volumn 17, Issue 6, 2012, Pages 561-568

  Naganuma, Toshihide ^a   Takemoto, Yoshiaki ^a   Shoji, Tetsuo ^a   Shima, Hideaki ^a   Ishimura, Eiji ^a   Okamura, Mikio ^b   Nakatani, Tatsuya ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Ohno Memorial Hospital   (Japan)

Author keywords

dialysis; magnetic resonance imaging; periventricular hyperintensity; subcortical white matter hyperintensity; white matter hyperintensities

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CEREBRAL WHITE MATTER HYPERINTENSITY; COMPRISING PERIVENTRICULAR HYPERINTENSITY; CONTROLLED STUDY; DEEP AND SUBCORTICAL WHITE MATTER HYPERINTENSITY; FEMALE; GROUPS BY AGE AND SEX; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BRAIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; JAPAN; LEUKOENCEPHALOPATHIES; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OVERWEIGHT; PREDICTIVE VALUE OF TESTS; PREVALENCE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; YOUNG ADULT;

EID: 84864454064     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2012.01596.x     Document Type: Article

References (46)

1. Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R,. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke 1986; 17: 1084-9. (Pubitemid 17008934)
2. Chowdhury MH, Nagai A, Bokura H, Nakamura E, Kobayashi S, Yamaguchi S,. Age-related changes in white matter lesions, hippocampal atrophy, and cerebral microbleeds in healthy subjects without major cerebrovascular risk factors. J. Stroke Cerebrovasc. Dis. 2011; 20: 302-9.
3. Longstreth WT, Jr, Manolio TA, Arnold A, et al,. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27: 1274-82. (Pubitemid 26286152)
4. Ginsberg MD, Hedley-Whyte ET, Richardson EP, Jr,. Hypoxic-ischemic leukoencephalopathy in man. Arch. Neurol. 1976; 33: 5-14.
5. Ovbiagele B, Saver JL,. Cerebral white matter hyperintensities on MRI: Current concepts and therapeutic implications. Cerebrovasc. Dis. 2006; 22: 83-90. (Pubitemid 44114448)
6. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC,. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002; 1: 426-36. (Pubitemid 37159153)
7. van Swieten JC, van den Hout JH, van Ketel BA, Hijdra A, Wokke JH, van Gijn J,. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 1991; 114 (Pt 2): 761-74.
8. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S,. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997; 28: 1932-9. (Pubitemid 27458998)
9. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM,. Silent brain infarcts and white matter lesions increase stroke risk in the general population: The Rotterdam Scan Study. Stroke 2003; 34: 1126-9. (Pubitemid 36547501)
10. Breteler MM, van Amerongen NM, van Swieten JC, et al,. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke 1994; 25: 1109-15. (Pubitemid 24164747)
11. Prins ND, van Dijk EJ, den Heijer T, et al,. Cerebral white matter lesions and the risk of dementia. Arch. Neurol. 2004; 61: 1531-4. (Pubitemid 39350263)
12. van Dijk EJ, Breteler MM, Schmidt R, et al,. The association between blood pressure, hypertension, and cerebral white matter lesions: Cardiovascular determinants of dementia study. Hypertension 2004; 44: 625-30. (Pubitemid 39435230)
13. Ikram MA, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, Breteler MM,. Kidney function is related to cerebral small vessel disease. Stroke 2008; 39: 55-61.
14. Khatri M, Wright CB, Nickolas TL, et al,. Chronic kidney disease is associated with white matter hyperintensity volume: The Northern Manhattan Study (NOMAS). Stroke 2007; 38: 3121-6. (Pubitemid 350175724)
15. Markus HS, Lythgoe DJ, Ostegaard L, O'Sullivan M, Williams SC,. Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI. J. Neurol. Neurosurg. Psychiatry 2000; 69: 48-53. (Pubitemid 30410414)
16. Martinez-Vea A, Salvado E, Bardaji A, et al,. Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD. Am. J. Kidney Dis. 2006; 47: 241-50. (Pubitemid 43121327)
17. Suzuki M, Wada A, Isaka Y, Maki K, Inoue T, Fukuhara Y,. Cerebral magnetic resonance T2 high intensities in end-stage renal disease. Stroke 1997; 28: 2528-31. (Pubitemid 28007662)
18. Takahashi W, Tsukamoto Y, Takizawa S, Kawada S, Takagi S,. Relationship between chronic kidney disease and white matter hyperintensities on magnetic resonance imaging. J. Stroke Cerebrovasc. Dis. 2010; 21: 18-23.
19. Fazekas G, Fazekas F, Schmidt R, Kapeller P, Offenbacher H, Krejs GJ,. Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J. Neurol. Sci. 1995; 134: 83-8.
20. Kim CD, Lee HJ, Kim DJ, et al,. High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis. Am. J. Kidney Dis. 2007; 50: 98-107.
21. Naganuma T, Takemoto Y, Yamasaki T, et al,. Factors associated with silent cerebral microbleeds in hemodialysis patients. Clin. Nephrol. 2011; 75: 346-55.
22. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA,. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am. J. Roentgenol. 1987; 149: 351-6. (Pubitemid 17104996)
23. Fazekas F, Kleinert R, Offenbacher H, et al,. The morphologic correlate of incidental punctate white matter hyperintensities on MR images. AJNR Am. J. Neuroradiol. 1991; 12: 915-21.
24. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-97.
25. Breteler MM, van Swieten JC, Bots ML, et al,. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study. Neurology 1994; 44: 1246-52. (Pubitemid 24232223)
26. Liao D, Cooper L, Cai J, et al,. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 1996; 27: 2262-70. (Pubitemid 26427203)
27. Park K, Yasuda N, Toyonaga S, et al,. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007; 69: 974-8. (Pubitemid 47366050)
28. Ito S, Nagasawa T, Abe M, Mori T,. Strain vessel hypothesis: A viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Hypertens. Res. 2009; 32: 115-21.
29. Turner ST, Rule AD, Schwartz GL, et al,. Risk factor profile for chronic kidney disease is similar to risk factor profile for small artery disease. J. Hypertens. 2011; 29: 1796-801.
30. Eiselt J, Rajdl D, Racek J, Siroka R, Trefil L, Opatrna S,. Asymmetric dimethylarginine in hemodialysis, hemodiafiltration, and peritoneal dialysis. Artif. Organs 2010; 34: 420-5.
31. Ueda S, Yamagishi S, Okuda S,. New pathways to renal damage: Role of ADMA in retarding renal disease progression. J. Nephrol. 2010; 23: 377-86.
32. Friedman AN, Bostom AG, Selhub J, Levey AS, Rosenberg IH,. The kidney and homocysteine metabolism. J. Am. Soc. Nephrol. 2001; 12: 2181-9. (Pubitemid 32880357)
33. Khan U, Hassan A, Vallance P, Markus HS,. Asymmetric dimethylarginine in cerebral small vessel disease. Stroke 2007; 38: 411-3. (Pubitemid 46184317)
34. Wright CB, Paik MC, Brown TR, et al,. Total homocysteine is associated with white matter hyperintensity volume: The Northern Manhattan Study. Stroke 2005; 36: 1207-11. (Pubitemid 40798740)
35. de Leeuw FE, de Groot JC, Achten E, et al,. Prevalence of cerebral white matter lesions in elderly people: A population based magnetic resonance imaging study. The Rotterdam Scan Study. J. Neurol. Neurosurg. Psychiatry 2001; 70: 9-14. (Pubitemid 32096113)
36. Dufouil C, de Kersaint-Gilly A, Besancon V, et al,. Longitudinal study of blood pressure and white matter hyperintensities: The EVA MRI Cohort. Neurology 2001; 56: 921-6. (Pubitemid 32290809)
37. Longstreth WT, Jr,. Brain abnormalities in the elderly: Frequency and predictors in the United States (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group. J. Neural Transm. Suppl. 1998; 53: 9-16. (Pubitemid 28361765)
38. Sachdev PS, Parslow R, Wen W, Anstey KJ, Easteal S,. Sex differences in the causes and consequences of white matter hyperintensities. Neurobiol. Aging 2009; 30: 946-56.
39. van den Heuvel DM, Admiraal-Behloul F, ten Dam VH, et al,. Different progression rates for deep white matter hyperintensities in elderly men and women. Neurology 2004; 63: 1699-701. (Pubitemid 39507592)
40. Jeerakathil T, Wolf PA, Beiser A, et al,. Stroke risk profile predicts white matter hyperintensity volume: The Framingham Study. Stroke 2004; 35: 1857-61. (Pubitemid 38971865)
41. Gouw AA, van der Flier WM, Fazekas F, et al,. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: The Leukoaraiosis and Disability study. Stroke 2008; 39: 1414-20.
42. Taylor WD, MacFall JR, Provenzale JM, et al,. Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients: Correlation with vascular risk factors. AJR Am. J. Roentgenol. 2003; 181: 571-6. (Pubitemid 36909511)
43. Wada M, Nagasawa H, Kawanami T, et al,. Cystatin C as an index of cerebral small vessel disease: Results of a cross-sectional study in community-based Japanese elderly. Eur. J. Neurol. 2010; 17: 383-90.
44. Wada M, Nagasawa H, Kurita K, et al,. Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects. J. Neurol. Sci. 2007; 255: 27-34. (Pubitemid 46414018)
45. Delano-Wood L, Abeles N, Sacco JM, Wierenga CE, Horne NR, Bozoki A,. Regional white matter pathology in mild cognitive impairment: Differential influence of lesion type on neuropsychological functioning. Stroke 2008; 39: 794-9. (Pubitemid 351619581)
46. Matsusue E, Sugihara S, Fujii S, Ohama E, Kinoshita T, Ogawa T,. White matter changes in elderly people: MR-pathologic correlations. Magn. Reson. Med. Sci. 2006; 5: 99-104.